stars 1 stars 2 stars 3

Aevus Precision Diagnostics’ mission is to empower physicians and other healthcare providers by harnessing the diagnostic powers of pharmacogenomics. Aevus is in its first year of transition into a well-formed, evidence-based genetic testing and diagnostic company, and is the way for physicians to more accurately prescribe diabetic medication by matching a diabetic patient with pharmaceuticals that best suit them based on their genetic profile. Aevus aims to reduce the number of ADRs that diabetic patients experience and offer physicians valuable information about how to best develop a targeted treatment plan from information collected through a prescribed saliva test. Unlike other genetic tests on the market that test for likelihood of disease development and ancestry, Aevus’ test will help diabetic patients achieve better results from their medication. Aevus Precision Diagnostics - Empowering Physicians through Pharmacogenomics

Aevus Precision Diagnostics Questions

The Aevus Precision Diagnostics annual revenue was $1 million in 2026.

Aevus Precision Diagnostics is based in Oklahoma City, Oklahoma.

The NAICS codes for Aevus Precision Diagnostics are [6215, 621, 62151, 62].

The SIC codes for Aevus Precision Diagnostics are [807, 8071, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users